|
Secondary prevention
Citations 421-430 of 566 total displayed.
|
Past content
(since Feb 1999):
|
- Current Perspectives
Need to Test the Arterial Inflammation Hypothesis
- Deepak L. Bhatt and Eric J. Topol
Circulation 2002;106:136-140, doi:10.1161/01.CIR.0000021112.29409.A2
[Full text]
- Articles
Change in Systolic Left Ventricular Performance After 3 Years of Antihypertensive Treatment. The Losartan Intervention for Endpoint (LIFE) Study
- Kristian Wachtell, Vittorio Palmieri, Michael H. Olsen, Eva Gerdts, Vasilios Papademetriou, Markku S. Nieminen, Gunnar Smith, Björn Dahlöf, Gerard P. Aurigemma, and Richard B. Devereux
Circulation published June 17, 2002, doi:10.1161/01.CIR.0000021601.49664.2A
[Abstract]
- Editorials
Myocardial Infarct: No One Size Fits All
- Marc A. Pfeffer and John J.V. McMurray
Circulation 2002;105:2577-2579, doi:10.1161/01.CIR.0000020729.75885.39
[Full text]
- Clinical Investigations and Reports
Prevention of Inflammation-Induced Endothelial Dysfunction: A Novel Vasculo-Protective Action of Aspirin
- Rajesh K. Kharbanda, Benjamin Walton, Meredith Allen, Nigel Klein, Aroon D. Hingorani, Raymond J. MacAllister, and Patrick Vallance
Circulation 2002;105:2600-2604; published online before print as doi:10.1161/01.CIR.0000017863.52347.6C
[Abstract]
[Full text]
- Clinical Investigations and Reports
Tea Consumption and Mortality After Acute Myocardial Infarction
- Kenneth J. Mukamal, Malcolm Maclure, James E. Muller, Jane B. Sherwood, and Murray A. Mittleman
Circulation 2002;105:2476-2481; published online before print as doi:10.1161/01.CIR.0000017201.88994.F7
[Abstract]
[Full text]
- Clinical Investigations and Reports
Safety and Tolerability of Pravastatin in Long-Term Clinical Trials: Prospective Pravastatin Pooling (PPP) Project
- Marc A. Pfeffer, Anthony Keech, Frank M. Sacks, Stuart M. Cobbe, Andrew Tonkin, Robert P. Byington, Barry R. Davis, Carola P. Friedman, and Eugene Braunwald
Circulation 2002;105:2341-2346; published online before print as doi:10.1161/01.CIR.0000017634.00171.24
[Abstract]
[Full text]
- Articles
Prevention of Inflammation-Induced
Endothelial Dysfunction. A Novel Vasculo-Protective Action of
Aspirin
- Rajesh K. Kharbanda, Benjamin Walton, Meredith Allen, Nigel Klein, Aroon D. Hingorani, Raymond J. MacAllister, and Patrick Vallance
Circulation published May 13, 2002, doi:10.1161/01.CIR.0000017863.52347.6C
[Abstract]
- AHA Conference Proceedings
Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group I: Epidemiology
- Barbara V. Howard, Beatriz L. Rodriguez, Peter H. Bennett, Maureen I. Harris, Richard Hamman, Lewis H. Kuller, Thomas A. Pearson, and Judith Wylie-Rosett
Circulation 2002;105:e132-137e, doi:10.1161/01.CIR.0000013953.41667.09
[Full text]
- AHA Conference Proceedings
Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group II: Pathogenesis of Atherosclerosis in Diabetes
- Robert H. Eckel, Momtaz Wassef, Alan Chait, Burton Sobel, Eugene Barrett, George King, Maria Lopes-Virella, Jane Reusch, Neil Ruderman, George Steiner, and Helen Vlassara
Circulation 2002;105:e138-143e, doi:10.1161/01.CIR.0000013954.65303.C5
[Full text]
- AHA Conference Proceedings
Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group III: Risk Assessment in Persons With Diabetes
- Rita F. Redberg, Philip Greenland, Valentin Fuster, Kalevi Pyörälä, Steven N. Blair, Aaron R. Folsom, Anne B. Newman, Daniel H. O’Leary, Trevor J. Orchard, Bruce Psaty, J. Sanford Schwartz, Rodman Starke, and Peter W.F. Wilson
Circulation 2002;105:e144-152e, doi:10.1161/01.CIR.0000013955.34262.AF
[Full text]
|
|
